Conclusions Compared with RF ablation , cryoablation present a comparable long-term AF/atrial tachycardial-free survival and procedure-related adverse events .
Meanwhile , cryoablation markedly shorten the procedure time , nonetheless , with negligible impact on the fluoroscopy time
Aims Cryoablation is a promising alternative technique to RF ablation for treating paroxysmal AF with encouraging results .
However , data about the efficacy and safety comparison between cryoablation and RF ablation is still lacking .
Results from a multicentre comparison of cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: is cryoablation more reproducible?
Aim Cryoballoon ablation ( Cryoballoon ) has emerged as a new alternative for the treatment of  symptomatic drug-refractory atrial fibrillation ( AF ) . Whether the results of Cryoballoon are more reproducible than those of radiofrequency ( RF ) ablation remains to be proved . Methods and results A total of 860 consecutive patients undergoing a first ablation procedure for paroxysmal AF ( 467 treated with RF and 393 treated with Cryoballoon ) were selected from a prospect i ve multicentre survey of AF ablation ( FrenchAF ) .  Radiofrequency and Cryoballoon were compared regarding mid-term efficacy and safety . During a median follow-up of 14 months ( interquartile range 8–23 ) , patients treated with Cryoballoon displayed similar rates of freedom from atrial arrhythmia relapse in centres performing this technique ( 68–80 % at 18 months ) . However , in centres performing RF , a greater heterogeneity in procedural results was observed ( 46–79 % were free from atrial arrhythmia relapse at 18 months ) . On multivariate analysis , Cryoballoon ( HR = 0.47 , 95 % CI 0.35–0.65 , P < 0.001 ) and annual AF ablation caseload ( HR = 0.87 per every 100 AF ablation procedures per year ; 95 % CI 0.80–0.96 , P = 0.003 ) were independent predictors of procedural success . However , on sensitivity analysis , according to the ablation method , annual AF ablation caseload predicted only sinus rhythm maintenance in the subgroup of patients treated with RF . Analysis of interoperator results with Cryoballoon and RF confirmed lower reproducibility of RF , but suggested that besides caseload , other operator-related factors may play a role . Conclusion Cryoballoon seems to be less operator-dependent and more reproducible than RF in the setting of paroxysmal AF ablation
Conclusions Compared with RF ablation , cryoablation present a comparable long-term AF/atrial tachycardial-free survival and procedure-related adverse events .
Meanwhile , cryoablation markedly shorten the procedure time , nonetheless , with negligible impact on the fluoroscopy time
Aims Cryoablation is a promising alternative technique to RF ablation for treating paroxysmal AF with encouraging results .
However , data about the efficacy and safety comparison between cryoablation and RF ablation is still lacking .